دورية أكاديمية

Adverse effect of Tamarindus indica and tamoxifen combination on redox balance and genotoxicity of breast cancer cell.

التفاصيل البيبلوغرافية
العنوان: Adverse effect of Tamarindus indica and tamoxifen combination on redox balance and genotoxicity of breast cancer cell.
المؤلفون: Guneidy RA; Department of Molecular Biology, Biotechnology Research Institute, National Research Centre, Cairo, Egypt. rasha_a_m_g@hotmail.com., Zaki ER; Department of Molecular Biology, Biotechnology Research Institute, National Research Centre, Cairo, Egypt., Karim GSAA; Department of Molecular Biology, Biotechnology Research Institute, National Research Centre, Cairo, Egypt., Saleh NS; Department of Molecular Biology, Biotechnology Research Institute, National Research Centre, Cairo, Egypt., Shokeer A; Department of Molecular Biology, Biotechnology Research Institute, National Research Centre, Cairo, Egypt.
المصدر: Journal, genetic engineering & biotechnology [J Genet Eng Biotechnol] 2023 Nov 21; Vol. 21 (1), pp. 131. Date of Electronic Publication: 2023 Nov 21.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101317150 Publication Model: Electronic Cited Medium: Internet ISSN: 2090-5920 (Electronic) Linking ISSN: 1687157X NLM ISO Abbreviation: J Genet Eng Biotechnol
أسماء مطبوعة: Publication: 2024- : [Amsterdam, Netherlands] : Elsevier B.V.
Original Publication: [Cairo] : Academy of Scientific Research and Technology, Information and Scientific Services Sector, National Information and Documentation Center
مستخلص: Background: Breast cancer is the most significant threat to women worldwide. Most chemotherapeutic drugs cause cancer cell death and apoptosis by inducing oxidative stress and producing reactive oxygen species (ROS). Cancer cells have a higher rate of metabolic activity than normal cells and thus produce more ROS. Glutathione and its related enzymes are the most significant antioxidant defense mechanisms that protect cells from oxidative and chemotherapeutic impacts. The anticancer actions of phenolic compounds were greatly confirmed. Using phenolic compounds as drugs in combination with chemotherapy may improve health, improve treatment outcomes, and reduce dose and damage. The goal of the study was to treat breast cancer cell lines (MCF-7) with Tamarindus indica extract individually and in combination with the anticancer drug tamoxifen (TAM) to improve therapeutic efficacy.
Results: After 48 h of incubation at IC 25 concentrations of T. indica extract (47.3 g/mL), tamoxifen (0.8 g/mL), and their co-treatments, the biochemical and genotoxic effects on MCF-7 cell lines were investigated. In MCF7 cell lines, T. indica extract increased reduced glutathione levels as well as glutathione transferase, glutathione peroxidase, and glutathione reductase activities. The same was true for oxidative state indicators, where higher levels of catalase and lactate dehydrogenase activity were associated with higher levels of malondialdehyde. T. indica has almost no effect on the DNA damage parameters. All of these variations can produce alterations in cancer cell genotoxicity and apoptotic pathways, explaining the restoration of DNA moment to normal levels and enhanced survival.
Conclusion: Cytotoxic and genotoxic effect of treatment with T. indica extract could be attributed to the dynamic interaction of glutathione cycle and antioxidant enzymes to combat oxidative stress, which can be considered as a positive therapeutic effect. On the other hand, the negative response of tamoxifen efficacy when co-treated with T. indica reversed tamoxifen's genotoxicity and enhanced survival.
(© 2023. The Author(s).)
References: Sci Rep. 2016 Feb 17;6:21164. (PMID: 26883574)
Biomed Res Int. 2021 Jan 18;2021:6049728. (PMID: 33623782)
Oxid Med Cell Longev. 2016;2016:7432797. (PMID: 27738491)
J Biomol Struct Dyn. 2021 Mar;39(5):1744-1753. (PMID: 32141392)
J Intercult Ethnopharmacol. 2014 Apr-Jun;3(2):68-72. (PMID: 26401350)
J Genet Eng Biotechnol. 2020 Nov 19;18(1):74. (PMID: 33215267)
Int J Cancer. 2021 Apr 5;:. (PMID: 33818764)
J Neurochem. 2018 Jan;144(1):93-104. (PMID: 29105080)
Biomolecules. 2020 Feb 03;10(2):. (PMID: 32028623)
J Neurosci. 2004 Feb 18;24(7):1531-40. (PMID: 14973232)
J Cell Biol. 2018 Jul 2;217(7):2291-2298. (PMID: 29915025)
Food Chem. 2018 Jan 15;239:385-401. (PMID: 28873583)
Biochem Pharmacol. 2015 Dec 1;98(3):371-80. (PMID: 26206193)
Discov Oncol. 2021 May 27;12(1):17. (PMID: 35201439)
Int J Mol Sci. 2019 Sep 14;20(18):. (PMID: 31540128)
RSC Adv. 2018 Apr 26;8(28):15831-15841. (PMID: 35539507)
J Lab Clin Med. 1967 Jul;70(1):158-69. (PMID: 6066618)
Anal Biochem. 1976 May 7;72:248-54. (PMID: 942051)
Redox Biol. 2019 Jun;24:101168. (PMID: 30925293)
CA Cancer J Clin. 2022 Jan;72(1):7-33. (PMID: 35020204)
Antioxidants (Basel). 2020 May 25;9(5):. (PMID: 32466263)
Biomedicines. 2022 May 26;10(6):. (PMID: 35740268)
Cell Oncol (Dordr). 2019 Apr;42(2):131-141. (PMID: 30645730)
Front Public Health. 2022 Apr 25;10:839835. (PMID: 35548083)
Biomed Res Int. 2018 Mar 25;2018:2024602. (PMID: 29770327)
Cancer Res. 1970 Apr;30(4):998-1002. (PMID: 4251323)
Anal Biochem. 1979 Jun;95(2):351-8. (PMID: 36810)
Sci Rep. 2020 Nov 11;10(1):19588. (PMID: 33177647)
Prev Nutr Food Sci. 2022 Sep 30;27(3):282-298. (PMID: 36313063)
Clin Neurophysiol. 2017 Oct;128(10):2022-2028. (PMID: 28837908)
J Pharmacol Pharmacother. 2011 Apr;2(2):107-11. (PMID: 21772771)
Signal Transduct Target Ther. 2021 Jun 28;6(1):242. (PMID: 34176927)
Arch Biochem Biophys. 1979 Nov;198(1):241-6. (PMID: 507842)
Environ Mol Mutagen. 2000;35(3):206-21. (PMID: 10737956)
J Biol Chem. 1974 Nov 25;249(22):7130-9. (PMID: 4436300)
Oxid Med Cell Longev. 2018 Mar 26;2018:6039453. (PMID: 29770168)
Methods Enzymol. 1984;105:121-6. (PMID: 6727660)
Front Pharmacol. 2020 Dec 09;11:592912. (PMID: 33362547)
Nutrients. 2022 Apr 10;14(8):. (PMID: 35458136)
Cell Mol Biol Lett. 2022 Jan 3;27(1):1. (PMID: 34979906)
معلومات مُعتمدة: 121104 National research centre, Cairo, Egypt
فهرسة مساهمة: Keywords: Breast cancer; Combination treatment; Genotoxicity; Glutathione-related enzymes; Oxidative stress; Plant cytotoxicity; Tamoxifen
تواريخ الأحداث: Date Created: 20231121 Latest Revision: 20231124
رمز التحديث: 20231124
مُعرف محوري في PubMed: PMC10663423
DOI: 10.1186/s43141-023-00564-z
PMID: 37987952
قاعدة البيانات: MEDLINE
الوصف
تدمد:2090-5920
DOI:10.1186/s43141-023-00564-z